View Cart  

Impax Can Launch Generic Renvela, Renagel in 2014 Under Genzyme Deal

A A
Impax Laboratories can market generic versions of Genzyme’s kidney disease drugs Renvela and Renagel in 2014 under a settlement with the brand drugmaker.

To View This Article:

Login

Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00